APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 10.0% | 7.8% | 7.5% | 14.8% | 15.1% | 10.2% | |
| – | – | – | – | – | – | 90.0% | 92.2% | 92.5% | 85.2% | 84.9% | 89.8% | |
| – | – | – | – | – | – | 119.7% | 632.3% | 513.4% | 89.4% | 41.9% | 29.5% | |
| – | – | – | – | – | – | 55.6% | 265.6% | 367.5% | 126.3% | 53.5% | 54.8% | |
| – | – | – | – | – | – | 175.3% | 897.9% | 880.9% | 215.6% | 106.0% | 84.3% | |
| – | – | – | – | – | – | -85.3% | -805.7% | -788.4% | -130.4% | -21.1% | 5.5% | |
| – | – | – | – | – | – | 11.9% | 19.9% | 43.3% | 7.5% | 5.2% | 4.4% | |
| – | – | – | – | – | – | -136.9% | -1,120.7% | -863.8% | -132.8% | -25.2% | 2.4% | |
| – | – | – | – | – | – | 0.7% | 0.5% | 0.9% | 0.5% | 0.1% | 0.2% | |
| – | – | – | – | – | – | -137.6% | -1,121.3% | -864.7% | -133.3% | -25.3% | 2.2% | |
| – | – | – | – | – | – | -124.6% | -1,098.6% | -818.6% | -124.9% | -19.8% | 7.0% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.